Vetsys Pharmaceutical
Vetsys Pharmaceutical
The global polymer additives market is experiencing a transformative era, currently valued at over USD 50 billion and projected to grow steadily. As industries shift toward lightweight materials in automotive manufacturing, high-purity components in medical devices, and sustainable packaging solutions, the demand for specialized additives—such as stabilizers, flame retardants, and processing aids—has reached an all-time high. Polymer additives are no longer just "fillers"; they are the fundamental building blocks that define the durability, safety, and functionality of modern materials.
Three core trends are reshaping the additive industry: Sustainability, Functionalization, and Digitalization. The global push for a circular economy has led to the development of bio-based additives and recyclability enhancers that help plastics maintain their properties through multiple life cycles. Additionally, "Smart Additives" are emerging, providing polymers with antimicrobial properties, enhanced conductivity, or UV-responsive capabilities. Manufacturers are now utilizing AI-driven molecular modeling to create bespoke additive formulations that meet precise engineering requirements.
Procurement teams worldwide are increasingly seeking Vertical Integration and Supply Chain Resilience. With the complexities of international logistics, global buyers are looking for reliable China-based manufacturers who can offer "one-stop-shop" solutions—from raw material synthesis to final product packaging. Compliance with international standards (such as GMP, REACH, and ISO) is non-negotiable, as companies in Europe and North America prioritize suppliers who demonstrate rigorous quality control and environmental stewardship.
Established in 2005, Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys) has evolved from a specialized regional producer into a global leader in high-purity chemical and pharmaceutical additives. With a registered capital of 30 million RMB, our infrastructure represents the pinnacle of Chinese industrial capability.
Our facility is a powerhouse of production, featuring dedicated workshops for a diverse range of high-demand products, including powders, premixes, injections, oral solutions, and granules. By 2015, Vetsys achieved a milestone of USD 20 million in annual domestic sales, a testament to our market authority and the trust placed in us by thousands of industrial partners.
We operate in strict compliance with Good Manufacturing Practices (GMP), ensuring every batch of Lithium Heparin, Sodium Bicarbonate, or Viscosity Index Improvers meets the most stringent international purity benchmarks.
Our Lithium Heparin 9045-22-1 is the gold standard for extracorporeal blood anticoagulation. Vital for clinical chemistry and blood gas analysis, our high-purity powder ensures that medical disposables and collection tubes provide accurate results without interfering with electrolyte balances, supporting hospitals and labs worldwide.
In the heavy machinery and automotive sectors, our Polymethacrylate (PAMA) Viscosity Index Improvers allow mineral base oils to achieve PAO-level performance. Simultaneously, our anti-fungal paint additives protect architectural integrity in humid climates, ensuring long-lasting, smooth wall coatings for both interior and exterior applications.
Modern feed mills rely on our Xylanase and Phytase enzymes to enhance nutrient absorption in livestock, reducing waste and increasing yield. Combined with our 99% purity Sodium Bicarbonate, we provide a holistic approach to animal nutrition and pH balance, driving efficiency in the global food supply chain.
Technological Innovation and Research: Vetsys distinguishes itself from competitors by placing a strong emphasis on technological development and continuous innovation. We have established an independent research institute equipped with five specialized laboratories and a team of world-class scientists. This enables us to quickly adapt to market demands and produce cutting-edge solutions for polymer science and animal health.
Quality Management: Quality is the cornerstone of our operations. We adhere to rigorous GMP standards, ensuring that all products are manufactured under optimal conditions and undergo extensive quality control checks before reaching the market. Our focus on sustainability also drives us to invest in green technologies, minimizing our environmental footprint while maximizing product efficacy.
As part of our long-term vision, Vetsys is deeply committed to environmental stewardship. We continue to invest in green technologies and eco-friendly manufacturing practices to minimize our operational impact. Our products are designed not only for industrial efficacy but also to promote the overall well-being of the ecosystems they serve.
In addition to our strong domestic presence, Vetsys is actively expanding its international footprint. Our future strategy includes strategic global partnerships, research collaborations with international institutes, and the expansion of our manufacturing capabilities to meet the increasing global demand for safe, effective, and high-performance polymer and chemical additives.
Our Vision: At Vetsys, we are driven by a mission to improve industrial and animal health through continuous innovation, world-class quality, and sustainable practices. We remain committed to creating value for our customers, employees, and society as we continue to shape the future of the additive industry.
